Tagamet HB to be available in 200 mg tablets; Nicorette, Nicotrol off to flying start.
This article was originally published in The Tan Sheet
SMITHKLINE WILL RE-INTRODUCE TAGAMET HB IN 200 MG TABLETS to help solidify the Rx-to-OTC switch antacid in the face of withering competition in the marketplace, CEO Jan Leschly reported at Bear Stearn's annual health care conference in New York on Sept. 12. Tagamet HB (cimetidine), although initially marketed in 100 mg tablets, carries a recommended dosage of 200 mg twice daily for the prevention and relief of heartburn, acid indigestion and sour stomach.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC